Compare Novartis AG (NVS) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Trade Desk Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Trade Desk Inc trades at $18.25 (market cap $8.76B). The key difference: Novartis AG is far larger — about 33.1× Trade Desk Inc's market cap, and Novartis AG pays a 3.17% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals.
| NVS | TTD | |
|---|---|---|
Market Cap | $290.25B | $8.76B |
Sector | Health | Technology |
52-Week High | $168.62 | $89.76 |
52-Week Low | $113.50 | $17.33 |
Enterprise Value | $330.27B | $7.78B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
